PRESS RELEASE published on 07/29/2025 at 14:00, 1 year 2 months ago Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101 Eckert & Ziegler chosen as US manufacturer for Archeus' ART-101 radiopharmaceutical, targeting prostate cancer. Collaboration to support Phase 1 trial with state-of-the-art facility in Boston, MA Eckert & Ziegler Prostate Cancer Radiopharmaceutical ART-101 Archeus
BRIEF published on 07/28/2025 at 14:35, 1 year 2 months ago Eckert & Ziegler Completes Capital Increase, Prepares Share Split Liquidity Eckert & Ziegler Capital Increase Share Split Nuclear Medicine
PRESS RELEASE published on 07/28/2025 at 14:30, 1 year 2 months ago Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation. Eckert & Ziegler SE increases capital and prepares for share split, aiming to enhance share liquidity and trading. Leading in isotope-related components for nuclear medicine and radiation therapy Liquidity Eckert & Ziegler Capital Increase Share Split Isotope-related Components
BRIEF published on 07/15/2025 at 14:05, 1 year 2 months ago Eckert & Ziegler's Training Program Recognized for Excellence Training Excellence Berlin Chamber Award Trainee Retention Career Prospects Future Applications
PRESS RELEASE published on 07/15/2025 at 14:00, 1 year 2 months ago Eckert & Ziegler: Outstanding Training Quality Once Again Awarded Eckert & Ziegler SE awarded for exceptional training quality by Berlin Chamber of Industry and Commerce for the fourth consecutive time, emphasizing practical experience and career prospects for trainees Eckert & Ziegler Career Prospects Training Quality Berlin Chamber Of Industry And Commerce Trainee Team
BRIEF published on 06/18/2025 at 16:10, 1 year 3 months ago Eckert & Ziegler SE Declares EUR 0.50 Dividend at Annual General Meeting Annual General Meeting Shareholders Dividend Financial Year 2024 Eckert & Ziegler SE
PRESS RELEASE published on 06/18/2025 at 16:05, 1 year 3 months ago Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50 Eckert & Ziegler SE's Annual General Meeting approves dividend of EUR 0.50 per share for 2024 fiscal year. Detailed voting results available online Annual General Meeting Shareholders Voting Results Dividend Eckert & Ziegler SE
BRIEF published on 06/05/2025 at 10:05, 1 year 3 months ago Eckert & Ziegler Expands with Approval of Illuccix® in Germany Gallium-68 Nuclear Medicine Prostate Cancer Illuccix® PSMA-PET Imaging
PRESS RELEASE published on 06/05/2025 at 10:00, 1 year 3 months ago Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany Eckert & Ziegler announces the approval of Illuccix® PSMA-PET Imaging Agent in Germany, expanding its nuclear medicine portfolio and partnership with Telix Pharmaceuticals Eckert & Ziegler Germany Approval Illuccix PSMA-PET
BRIEF published on 05/30/2025 at 10:05, 1 year 4 months ago Eckert & Ziegler Hosts Successful Boston Radionuclide Theranostics Forum Precision Oncology Industry Collaboration Radiopharmaceuticals Theranostics Forum Event Insights
Published on 10/02/2026 at 00:30, 4 hours 24 minutes ago Immutable Holdings Provides Corporate Update
Published on 10/01/2026 at 23:05, 5 hours 49 minutes ago Vox Royalty Expands Revolving Credit Facility Up to $150 Million and Strengthens Leadership Team
Published on 10/01/2026 at 22:00, 6 hours 54 minutes ago Golden Minerals Company Announces New Management Appointments and Resignation of Mr. Pablo Castanos
Published on 10/02/2026 at 04:05, 49 minutes ago Angel Aligner Upgrades Torque Ridges to "Pressure Points" in Europe
Published on 10/02/2026 at 00:01, 4 hours 53 minutes ago PolyPeptide publishes the invitation to its extraordinary general meeting of shareholders on 26 October 2026
Published on 10/01/2026 at 23:15, 5 hours 39 minutes ago CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies
Published on 10/01/2026 at 20:45, 8 hours 9 minutes ago Ditto Named a Product Leader in KuppingerCole Analysts Leadership Compass for Identity Verification
Published on 10/01/2026 at 20:30, 8 hours 24 minutes ago Eleving Group prices EUR 200 million senior secured bonds at 9% in private placement – EUR 25 million exchange offer to follow
Published on 10/01/2026 at 19:00, 9 hours 54 minutes ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 10 hours 14 minutes ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 10 hours 49 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 10/01/2026 at 18:00, 10 hours 53 minutes ago Saint-Gobain completes the acquisition of Xypex (North America), a leader in high value-added waterproofing solutions
Published on 10/01/2026 at 17:55, 10 hours 59 minutes ago Disclosure of transactions in own shares from September 28 to September 30, 2026